![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ![]() Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. | ||
Founding Date | Founding Date 2009 | Founding Date 1996 | Founding Date 2013 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Seattle, US HQ New York, US South San Francisco, US |
Employees | Employees 3,9671% decrease | Employees 75,883 | Employees 1091% decrease | Employees 70910% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) $277m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $71.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $205.6m (FY, 2025) |
Net income | Net income N/A | Net income $14b (FY, 2025) | Net income ($437.1m) (FY, 2017) | Net income ($59.5m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 6.5m | Total funding raised $ 310m | Total funding raised $ 525m |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View company